Ann: Appendix 4D & Half-Year Financial Statements, page-58

I haven't done a thorough analysis of the cost of doing a phase 2 GvHD trial - had I, I'd not object to you critiquing it.

You suggested you'd done some. I don't promise to critique it if you post it - it will likely depend on whether I consider it worth responding to - but if you don't then I definitely won't.

Let's assume you aren't going to wound or amaze me with a witty off topic deflection and save it.

I've paid you a compliment (I'm not fond of your posting style but I respect your intellect) and expressed an interest in hearing more of what you think about something you have been posting about repeatedly (the cost of a phase 2), so do as you wish now.

Your usual conversant awaits you.